Filing Details
- Accession Number:
- 0000904454-20-000417
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-06-24 16:21:16
- Reporting Period:
- 2020-06-23
- Accepted Time:
- 2020-06-24 16:21:16
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1590560 | Uniqure N.v. | QURE | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1716268 | Robert Gut | C/O Uniqure N.v. Paasheuvelweg 25A Amsterdam P7 1105BP | Chief Medical Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2020-06-23 | 5,000 | $35.40 | 50,875 | No | 4 | M | Direct | |
| Ordinary Shares | Acquisiton | 2020-06-23 | 21,875 | $39.97 | 72,750 | No | 4 | M | Direct | |
| Ordinary Shares | Disposition | 2020-06-23 | 26,875 | $70.00 | 45,875 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-06-23 | 5,000 | $0.00 | 5,000 | $35.40 |
| Ordinary Shares | Stock Option (Right to Buy) | Disposition | 2020-06-23 | 21,875 | $0.00 | 21,875 | $39.97 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 5,000 | 2028-06-14 | No | 4 | M | Direct | |
| 48,125 | 2028-09-18 | No | 4 | M | Direct |
Footnotes
- The shares were sold pursuant to a sales plan adopted by the Reporting Person and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934.
- The Stock Option vests over three years, with one-third vesting after twelve months from the date of grant (06/14/2018) and then one-twelfth every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date.
- The Stock Option vests over four years, with 25% vesting after twelve months from the date of grant (09/18/2018) and then 6.25% every three months thereafter, subject to the Reporting Person's continued relationship with the Issuer through each such date.
Billionaire Hedge Funds
